You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkin's disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)

Not yet recruiting
  • Hodgkin Disease
  • Morphological and functional magnetic resonance imaging (MRI)
  • Neuropsychological assessment
  • Arras, France
  • +3 more
Oct 31, 2023

Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Low-field magnetic resonance imaging
  • +3 more
  • Erlangen, Bavaria, Germany
    Department of Pediatrics and Adolescent Medicine
Oct 23, 2023

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +5 more
    • (no location specified)
    Nov 2, 2023

    Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Oct 18, 2022

    Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Sep 19, 2023

    Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • GEN3017
    • (no location specified)
    Aug 25, 2023

    Resting Heart Rate and Heart Rate Variability in Survivors of

    Active, not recruiting
    • Hodgkin Disease
      • Memphis, Tennessee
        Kirsten Ness
      Jan 23, 2023

      Cardiovascular Disease in Hodgkin Lymphoma Survivors

      Not yet recruiting
      • Hodgkin Lymphoma
      • +3 more
      • Patient Self Reporting
      • +2 more
      • (no location specified)
      Jan 20, 2023

      Hodgkin's Disease Trial in Boston (Echo/Stress Echo)

      Active, not recruiting
      • Hodgkin's Disease
      • Echo/Stress Echo
      • Boston, Massachusetts
      • +1 more
      Mar 28, 2022

      Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

      Recruiting
      • Classical Hodgkin Lymphoma
      • Zimberelimab 240mg
      • Guangzhou, Guangdong, China
        Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
      Jun 15, 2023

      Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

      Recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin 50 MG [Adcetris]
      • Leon, Guanajuato, Mexico
        Hospital Regional Alta Especialidad Bajio
      Oct 24, 2022

      Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

      Active, not recruiting
      • Hodgkin Lymphoma
      • Brentuximab Vedotin
      • +3 more
      • Valhalla, New York
        New York Medical College
      Sep 27, 2022

      Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

      Not yet recruiting
      • Classic Hodgkin Lymphoma
      • Concurrent penpulimab and AVD
      • Sequential penpulimab and AVD
      • (no location specified)
      Jul 10, 2023

      Quality of Life in Adult and Pediatric Nodular

      Recruiting
      • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
        • Aurora, Colorado
        • +1 more
        Oct 27, 2023

        Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

        Recruiting
        • Safety Issues
        • Efficacy, Self
        • low dose nivolumab in combination with AVD
        • Monterrey, Nuevo Leon, Mexico
          Hospital Universitario Dr Jose Eleuterio Gonzalez
        Mar 6, 2023

        Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

        Completed
        • Multiple Myeloma
        • +11 more
        • Pre-biotic foods/drinks
        • Charlottesville, Virginia
          University of Virginia
        Jan 2, 2023

        Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

        Not yet recruiting
        • Hodgkin Lymphoma
        • Brentuximab vedotin
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 20, 2023

        Clinical, Laboratory and Epidemiologic Characterization of

        Recruiting
        • Waldenstrom Macroglobulinemia
        • +4 more
          • Bethesda, Maryland
          • +1 more
          Jan 25, 2023

          Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)

          Recruiting
          • Relapsed or Refractory Hodgkin Lymphoma
          • Beijing, Beijing, China
            Han wei dong
          Jun 14, 2023

          Brazilian Prospective Hodgkin Lymphoma Registry

          Recruiting
          • Hodgkin Lymphoma
          • Hodgkin Disease
            • Rio de Janeiro, Brazil
              Universidade Federal Do Rio de Janeiro
            May 16, 2022

            Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

            Active, not recruiting
            • Hodgkin Lymphoma Survivor
            • Clinical Assessment
            • +2 more
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Dec 22, 2022

            Hodgkin Lymphoma Trial in Moscow (Nivolumab)

            Recruiting
            • Hodgkin Lymphoma
            • Moscow, Russian Federation
              The Federal Budget-Funded Institution National Medical Surgical
            Oct 31, 2022

            Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

            Recruiting
            • Lung Cancer
            • +8 more
            • Home-based cardiac rehabilitation
            • Saint Louis, Missouri
              Washington University School of Medicine
            Aug 9, 2022

            Recurrent/Refractory Classical Hodgkin's Lymphoma Trial in Tianjin (AK105,Anrotinib HCl)

            Enrolling by invitation
            • Recurrent/Refractory Classical Hodgkin's Lymphoma
            • AK105，Anrotinib hydrochloride
            • Tianjin, Tianjin, China
              Tianjin Medical University Cancer Insititute & Hospital
            Jan 12, 2023